|Bid||0.00 x 800|
|Ask||0.00 x 1800|
|Day's Range||76.10 - 78.30|
|52 Week Range||52.83 - 80.19|
|Beta (3Y Monthly)||0.61|
|PE Ratio (TTM)||62.12|
|Earnings Date||Jan 31, 2019 - Feb 4, 2019|
|Forward Dividend & Yield||2.20 (2.87%)|
|1y Target Est||79.12|
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon and Netflix ranked among the top 30 picks and both lost around 20%. Facebook, which was the second most popular stock, lost 14% amid uncertainty regarding the interest rates and tech valuations. […]
The $1.4 billion Moderna lost in value is greater than the market value of more than half the companies in the Nasdaq Biotechnology Index. The company boasts partnerships with sector juggernauts including Merck & Co. and AstraZeneca Plc, so its growth prospects have attracted notable attention across the sector.
Despite the volatile market, these 16 stocks to watch are showing relative strength and may pop if the stock market rebounds.
The " Fast Money " traders shared their first moves for the market open. Pete Najarian was a buyer of Merck MRK . Tim Seymour was a buyer of Boeing BA . Dan Nathan was a buyer of Disney DIS . Guy Adami was a buyer of Twitter TWTR .
Interim data indicate an excellent safety profile for the combination regimen in advanced breast cancer patients. Confirmed positive proof-of-concept with Bria-IMT™ Monotherapy demonstrates promising anti-tumor activity with excellent safety and tolerability in advanced breast cancer patients.
Mylan (MYL) expands recall of batches of blood pressure medicine in the United States to include all Valsartan-based products within expiry.
NEW YORK, NY / ACCESSWIRE / December 5, 2018 / U.S. equities plunged on Tuesday as skepticism over the U.S. and China’s ability to close a trade agreement weighed on the markets. The Dow Jones Industrial ...
“In health care alone, there are massive amounts of unstructured data generated every day in labs,” Michael Vande Vrede, head of digital products at Merck KGaA, said Tuesday at the conference on Neural Information Processing Systems (NeurIPS) in Montreal, where the two companies announced their collaboration. V7 has created software called Graphotate that makes it easier and faster to annotate scientific imagers and videos.
Shire's (SHPG) gets European approval for Takhzyro subcutaneous injection, for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older.
The Zacks Analyst Blog Highlights: General Motors, Boeing, Microsoft, Merck and UnitedHealth
Merck (MRK), known as MSD outside the United States and Canada, announced today that Robert M. Davis, chief financial offer and executive vice president, Merck Global Services, is scheduled to present at Citi’s 2018 Global Healthcare Conference in New York on Dec. 5, 2018 at 8:45 a.m. EST. For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases.
Novartis (NVS) gains the EU approval for MS drug Gilenya for children who are 10-17 years old with relapsing-remitting forms of multiple sclerosis.
U.S. stock futures are trading lower this morning as investors prepare for the G-20 meeting between President Trump and Chinese leader Xi Jinping. Over at the CBOE, the single-session equity put/call volume ratio cratered to 0.57 — a one-month low. Options activity was a mixed bag on Wednesday (Options traders zeroed in on analyst actions yesterday).
We take a look at some of the major pharma companies in the HIV market that are developing drugs to address the life-threatening disease.
The Zacks Analyst Blog Highlights: Boeing, Merck, Microsoft, UnitedHealth and American Express